PRF Technologies Ltd. vs Rockwell Medical, Inc. — Valuation Comparison 2026
Access all valuation models for PRFX vs RMTI — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.
Access Full Analysis — From $27/mo →RMTI scores higher with a 6.0/10 quality rating vs PRFX's 4.4/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.
Comparing PRF Technologies Ltd. (PRFX) and Rockwell Medical, Inc. (RMTI) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.
PRFX currently trades at $1.37 with a QOC of 4.4/10, while RMTI trades at $0.76 with a QOC of 6.0/10.
Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).